^
CANCER:

Thymoma

Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
No biomarker
Thymoma
GEM-CAP
Sensitive
:
A2
No biomarker
Thymoma
LV5FU2
Sensitive
:
A2
No biomarker
Thymoma
CaT
Sensitive
:
A2
No biomarker
Thymoma
VIP
Sensitive
:
A2
No biomarker
Thymoma
CAP
Sensitive
:
A2
No biomarker
Thymoma
etoposide IV
Sensitive
:
A2
No biomarker
Thymoma
ifosfamide
Sensitive
:
A2
No biomarker
Thymoma
CAP + prednisone
Sensitive
:
A2
No biomarker
Thymoma
ADOC
Sensitive
:
A2
No biomarker
Thymoma
EP
Sensitive
:
A2
No biomarker
Thymoma
carboplatin
Sensitive
:
A2
No biomarker
Thymoma
pembrolizumab
Resistant
:
A2
No biomarker
Thymoma
gemcitabine
Sensitive
:
A2
No biomarker
Thymoma
paclitaxel
Sensitive
:
A2
No biomarker
Thymoma
pemetrexed
Sensitive
:
A2
No biomarker
Thymoma
prednisone + octreotide
Sensitive
:
A2
No biomarker
Thymoma
octreotide
Sensitive
:
A2
No biomarker
Thymoma
everolimus
Sensitive
:
A2
IGF1R expression
Thymoma
everolimus
Resistant
:
C3
EIF4EBP1 expression
Thymoma
everolimus
Resistant
:
C3
PD-L1 overexpression
Thymoma
pembrolizumab
Sensitive
:
C4